Nuclear Receptors as Molecular Targets for Cardiometabolic and Central Nervous System Diseases
The cloning of the first nuclear receptor cDNA encoding the human glucocorticoid receptor was described in 1985 by the team of Evans [1]. Over the next 25 years a dramatic growth of knowledge on nuclear receptors followed this discovery [2]. The knowledge on nuclear receptors has delivered novel...
Đã lưu trong:
Những tác giả chính: | , |
---|---|
Định dạng: | Sách |
Ngôn ngữ: | English |
Được phát hành: |
IOS Press
2013
|
Những chủ đề: | |
Truy cập trực tuyến: | https://scholar.dlu.edu.vn/thuvienso/handle/DLU123456789/35229 |
Các nhãn: |
Thêm thẻ
Không có thẻ, Là người đầu tiên thẻ bản ghi này!
|
Thư viện lưu trữ: | Thư viện Trường Đại học Đà Lạt |
---|
id |
oai:scholar.dlu.edu.vn:DLU123456789-35229 |
---|---|
record_format |
dspace |
spelling |
oai:scholar.dlu.edu.vn:DLU123456789-352292014-01-20T00:05:45Z Nuclear Receptors as Molecular Targets for Cardiometabolic and Central Nervous System Diseases Junien, J.L Staels, B System Targets The cloning of the first nuclear receptor cDNA encoding the human glucocorticoid receptor was described in 1985 by the team of Evans [1]. Over the next 25 years a dramatic growth of knowledge on nuclear receptors followed this discovery [2]. The knowledge on nuclear receptors has delivered novel therapies for lipid control and hormone replacement, and for management of cancers and diabetes, and millions of humans were subjected to therapies with nuclear receptor modulators over last decades 2013-08-27T09:24:10Z 2013-08-27T09:24:10Z 2008 Book 978-1-58603-857-1 https://scholar.dlu.edu.vn/thuvienso/handle/DLU123456789/35229 en application/pdf IOS Press |
institution |
Thư viện Trường Đại học Đà Lạt |
collection |
Thư viện số |
language |
English |
topic |
System Targets |
spellingShingle |
System Targets Junien, J.L Staels, B Nuclear Receptors as Molecular Targets for Cardiometabolic and Central Nervous System Diseases |
description |
The cloning of the first nuclear receptor cDNA encoding the human glucocorticoid
receptor was described in 1985 by the team of Evans [1]. Over the next 25 years a dramatic
growth of knowledge on nuclear receptors followed this discovery [2]. The
knowledge on nuclear receptors has delivered novel therapies for lipid control and
hormone replacement, and for management of cancers and diabetes, and millions of
humans were subjected to therapies with nuclear receptor modulators over last decades |
format |
Book |
author |
Junien, J.L Staels, B |
author_facet |
Junien, J.L Staels, B |
author_sort |
Junien, J.L |
title |
Nuclear Receptors as Molecular
Targets for Cardiometabolic and
Central Nervous System Diseases |
title_short |
Nuclear Receptors as Molecular
Targets for Cardiometabolic and
Central Nervous System Diseases |
title_full |
Nuclear Receptors as Molecular
Targets for Cardiometabolic and
Central Nervous System Diseases |
title_fullStr |
Nuclear Receptors as Molecular
Targets for Cardiometabolic and
Central Nervous System Diseases |
title_full_unstemmed |
Nuclear Receptors as Molecular
Targets for Cardiometabolic and
Central Nervous System Diseases |
title_sort |
nuclear receptors as molecular
targets for cardiometabolic and
central nervous system diseases |
publisher |
IOS Press |
publishDate |
2013 |
url |
https://scholar.dlu.edu.vn/thuvienso/handle/DLU123456789/35229 |
_version_ |
1819796019389399040 |